Boehringer Ingelheim Launches Metalyse® 25 mg in Egypt Following Approval by the Egyptian Drug Authority
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has announced the introduction of…
Tag: Metalyse® 25 mg